FIELD: medicine.
SUBSTANCE: invention relates to medicine and is intended for prevention of ulcer formation in stomach, caused by application of non-steroid anti-inflammatory medications. Solution of taurine is applied in dose range from 3.5 to 14.3 mg/kg before meal. It is administered for 7 days before application of non-steroid anti-inflammatory medications.
EFFECT: method makes it possible to increase resistance of stomach mucosa to injury by non-steroid anti-inflammatory medications.
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREVENTION OF GASTRIC MUCOSAL DAMAGE CAUSED BY ADMINISTRATION OF NONSTEROID ANTI-INFLAMMATORY AGENTS | 2010 |
|
RU2449784C1 |
| COMPOUNDS DERIVED FROM TAURINE, METHODS FOR PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAID COMPOUNDS | 2009 |
|
RU2502729C2 |
| METHOD OF PREVENTION OF STOMACH ULCER LESION CAUSED BY NONSTEROID ANTIINFLAMMATORY AGENTS | 2007 |
|
RU2330671C1 |
| METHOD FOR DECREASING EROSIVE-ULCEROUS LESION OF GASTRIC MUCOSA AT THE IMPACT OF ACETYLSALICYLIC ACID (ASA) WITH THE HELP OF A PEPTIDE OF Arg-Tyr-D-Ala-Phe-Gly FORMULA | 2005 |
|
RU2303983C1 |
| AGENT FOR CANCER PROPHYLAXIS | 2005 |
|
RU2290178C1 |
| THE METHOD OF MODELING OF CHEMICAL GASTRITIS | 2010 |
|
RU2442227C2 |
| METHOD FOR PREVENTION OF NSAID-GASTROPATHY | 2018 |
|
RU2693044C1 |
| METHOD FOR TREATING PATIENTS WITH GASTRIC ULCER ASSOCIATED WITH NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAID) | 2019 |
|
RU2723457C1 |
| AGENT POSSESSING ANTIAGGREGANT, CYTOPROTECTIVE AND ANTIOXIDANT ACTIVITY | 2018 |
|
RU2694061C1 |
| GASTROPROTECTIVE MEDICATION | 2009 |
|
RU2406520C2 |
